23 completed, 13 unknown, 3 terminated, 2 recruiting. 43 Phase 2, 7 Phase 1, 4 Phase 3.
Follow Liver Transplantation: new trials by email Literature Review of Liver Transplantation trials Research Report on Liver Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Tolerance Induction After Liver Transplantation Donor Hematopoietic Stem and Progenitor Cell Infusion - Liver Transplantation, Immune Tolerance | Phase 1 / Phase 2 | Recruiting | University of California, Los Angeles | 12 | 2026-02-20 | 2026-03-12 |
| Secretin in Ex-situ Liver Perfusion Secretin administration during ex-situ liver machine perfusion - Liver Transplantation | Phase 1 / Phase 2 | Enrolling by invitation | Erasmus Medical Center | 20 | 2025-04-26 | 2026-06-16 |
| Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation Downstaging procedures containing immunotherapy, Liver transplantation - Liver Transplantation, Hepatocellular Carcinoma | Phase 2 | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 59 | 2023-06-21 | 2024-11-29 |
| A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation TCD601, Cyclophosphamide, TAC - Liver Transplantation | Phase 2 | Active not recruiting | ITB-Med LLC | 12 | 2022-06-29 | 2024-11-27 |
| A Feasibility Study of Octreotide Infusion During Liver Transplant. Octreotide Acetate, Placebo - Liver Transplantation, Renal Failure | Phase 2 | Unknown | University College, London | 30 | 2022-05-27 | 2023-05-03 |
| A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver Transplantation LIV-GAMMA SN Inj., No intervention - Liver Transplantation | Phase 2 | Terminated | SK Plasma Co., Ltd. | 59 | 2022-04-25 | 2024-08-30 |
| Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation [18F]FSPG - Graft Rejection, Heart Transplantation | Phase 2 | Completed | Asan Medical Center | 7 | 2020-11-18 | 2023-07-20 |
| Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation Ascorbic acid, 0.9% Saline solution - Liver Transplantation, Postreperfusion Syndrome | Phase 2 | Unknown | Hospital Universitario Ramon y Cajal | 70 | 2020-11-17 | 2023-03-03 |
| Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus lenvatinib, Placebo - Hepatocellular Carcinoma, Portal Vein Tumor Thrombus | Phase 2 / Phase 3 | Unknown | RenJi Hospital | 108 | 2020-05-02 | 2020-03-24 |
| Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation Immuncell-LC - Liver Transplantation | Phase 1 / Phase 2 | Completed | GC Cell Corporation | 19 | 2019-01-24 | 2023-06-22 |
| Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver Transplantation Omega 3 fatty acid - Liver Transplantation | Phase 2 | Unknown | Institute of Liver and Biliary Sciences, India | 124 | 2018-12-02 | 2019-07-23 |
| Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation Tacrolimus, Tacrolimus (Tacrolimus elimination), Sirolimus - Liver Transplantation | Phase 2 / Phase 3 | Unknown | Southern Medical University, China | 130 | 2018-05-01 | 2018-04-18 |
| Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation Terlipressin, Normal saline - Terlipressin Adverse Reaction, Liver Transplantation | Phase 2 | Completed | Kasr El Aini Hospital | 30 | 2018-01-25 | 2018-12-24 |
| Post Static Cold Storage Normothermic Machine Liver Perfusion Normothermic Machine Liver Perfusion - Liver Transplantation | Phase 1 / Phase 2 | Unknown | University of Oxford | 30 | 2017-05-01 | 2017-06-05 |
| Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients Interleukin-2 - Liver Transplantation | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 6 | 2016-11-01 | 2026-01-13 |
| Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation Immunosuppression withdrawal - Liver Transplant, Liver Transplantation | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 100 | 2015-12-15 | 2023-09-14 |
| Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation Mesenchymal Stem Cells(MSCs) - Liver Transplantation | Phase 1 / Phase 2 | Unknown | Third Affiliated Hospital, Sun Yat-Sen University | 15 | 2014-02-01 | 2016-03-11 |
| Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression. Extracorporeal Photopheresis Procedure (FEC) - Liver Transplantation, Immunosuppression | Phase 1 / Phase 2 | Completed | Red de Terapia Celular | 10 | 2013-04-01 | 2017-03-30 |
| Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients Immunosuppression withdrawal - Liver Transplant Recipients, Liver Transplantation | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 161 | 2012-08-14 | 2019-10-07 |
| A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time Tacrolimus, Tacrolimus prolonged release - Heart Transplantation, Kidney Transplantation | Phase 2 | Completed | Astellas Pharma Europe Ltd. | 44 | 2012-04-03 | 2024-11-01 |
Showing 20 of 43. Sign in to see all of them.
Carcinoma, Hepatocellular (4) · Hepatitis C (3) · Renal Insufficiency (3) · Hepatitis B (2) · Bone Resorption (1) · Cholestasis (1) · End Stage Liver Disease (1) · Hepatitis (1) · Invasive Fungal Infections (1) · Liver Diseases (1) · Mycoses (1) · Rejection, Psychology (1) · Renal Insufficiency, Chronic (1)
Digestive System Diseases (11) · Liver Diseases (10) · Infections (6) · Blood-Borne Infections (5) · Communicable Diseases (5) · Hepatitis (5) · Hepatitis, Viral, Human (5) · Virus Diseases (5) · Adenocarcinoma (4) · Carcinoma (4) · Digestive System Neoplasms (4) · Liver Neoplasms (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4)
Tacrolimus (11) · Mycophenolic Acid (5) · Saline Solution (3) · Liver Transplantation (2) · Prednisone (2) · Sirolimus (2) · Steroids (2) · 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-hepten-6-ynamide (1) · 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid (1) · 4-(3-fluoropropyl)glutamic acid (1) · Adrenal Cortex Hormones (1) · Alemtuzumab (1) · Alendronate (1) · Ascorbic Acid (1) · BID protein, human (1)
Astellas Pharma Inc (5) · Hospital Clinic of Barcelona (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Astellas Pharma Europe Ltd. (2) · Columbia University (2) · Armin Goralczyk (1) · Asan Medical Center (1) · Beijing Chao Yang Hospital (1) · Beth Israel Deaconess Medical Center (1) · Conatus Pharmaceuticals Inc. (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Erasmus Medical Center (1) · GC Cell Corporation (1) · Grupo de Estudio de Infecciones en Transplantados (1) · Hospital Universitario Ramon y Cajal (1)
United States (13) · Spain (10) · Germany (8) · France (7) · United Kingdom (7) · Italy (6) · Canada (5) · Czechia (5) · China (4) · South Korea (4) · Belgium (3) · Poland (3) · Austria (2) · Netherlands (2) · Sweden (2)
Alberto Sanchez-Fueyo, MD (2) · Giuseppe Tisone, MD (2) · Aiman Obed, PD Dr. (1) · Alberto Sanchez Fueyo, MD (1) · Andreas A Schnitzbauer, MD (1) · Armin D Goralczyk, Dr. (1) · Cray V. Noah, MD (1) · Dae Hyuk Moon, MD (1) · Deborah C. Molrine, MD (1) · Ding Ma, M.D. (1) · Elizabeth Shane, M.D. (1)
PMID 20380712, PMID 23024190, PMID 23356386, PMID 25677074, PMID 26729653, PMID 30178515, PMID 32786149, PMID 33280227, PMID 35819312, PMID 38100226, PMID 40719561, PMID 41128798, PMID 41500624
U01AI100807 (1)